Table 2.

Clinical details of post-transplant patients

Clinical Parameters	Post-transplant (n = 39)
Congenital Heart Disease	46% (18/39)
Median Time From Transplant (years, [IQR 25–75])	3 [1–9]
History of Rejection, n (%)	76% (30/39)
MCS Prior to Transplant, n (%)	38% (15/39)
Donor Ischemic Time (minutes, [IQR25–75])	210 [179–234]
Diuretics, n	28% (11/39)
Aspirin, n	53% (21/39)
Anticoagulation, n	7% (3/39)
Statin, n	15% (6/39)
ACEI, n	43% (17/39)
ARB, n	5% (2/39)
CCB, n	13% (5/39)
BB, n	10% (4/39)
Immunosuppression
Tacrolimus, n	97% (38/39)
Sirolimus, n	23% (9/39)
MMF, n	66% (26/39)
Steroids, n	41% (16/39)
Azathioprine, n	5% (2/39)

ACEI angiotensin converting enzyme inhibitor, ARB angiotensin receptor blocker, CCB calcium channel blocker, BB Beta Blocker, MMF mycophenolic acid